Serge Camelo
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.
Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.
Journal: International journal of molecular sciences
Published: January 06, 2025
Modulation of the renin-angiotensin system against COVID-19: A path forward?
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 03, 2024
RAR Inhibitors Display Photo-Protective and Anti-Inflammatory Effects in A2E Stimulated RPE Cells In Vitro through Non-Specific Modulation of PPAR or RXR Transactivation.
Journal: International journal of molecular sciences
Published: December 20, 2023
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.
Journal: EClinicalMedicine
Published: July 10, 2023
Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD).
Journal: International journal of molecular sciences
Published: January 02, 2023
Structural analysis of unstable norbixin isomers guided by pure shift nuclear magnetic resonance.
Journal: Magnetic resonance in chemistry : MRC
Published: December 17, 2021
A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.
Journal: Emerging microbes & infections
Published: November 16, 2021
A2E-induced inflammation and angiogenesis in RPE cells in vitro are modulated by PPAR-α, -β/δ, -γ, and RXR antagonists and by norbixin.
Journal: Aging
Published: November 21, 2020
Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients.
Journal: Drug discovery today
Published: October 08, 2020
Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors.
Journal: Oxidative medicine and cellular longevity
Published: July 24, 2020
Last Updated: 09/26/2026